Apr. 14, 2023
Bayer investors suing over Monsanto acquisition argue for class status
Because the investors did not purchase Bayer securities in the United States, the company’s attorney asserted, they cannot bring claims under Section 10(b) of the Securities Act because the law limits such claims to transactions in securities listed on domestic exchanges and domestic transactions in other securities.
Attorneys representing Bayer AG investors argued before a federal judge Thursday that their securities fraud cases should be granted class certification because class actions are “virtually always the fairest and most efficient way” to litigate such claims.
“It’s actually a straightforward, run of the mill Section 10(b) case about domestic securities,” asserted plaintiffs’ attorney Benjamin F. Jackson of Cohen Milstein Sellers & Toll ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In